术前放疗改善直肠印戒细胞癌生存:基于人群的研究
该回顾性研究利用SEER项目纳入1988至2012年292例II-III期直肠印戒细胞癌患者,比较术前放疗、术后放疗与单纯手术对病因特异性生存(CSS)的影响。多因素分析显示术前放疗是III期患者CSS的独立预测因素,术前与术后放疗组CSS相当。
要点
- 术前放疗较单纯手术改善CSS,尤其在III期患者中。
- 多因素分析证实术前放疗是III期直肠SRCC的CSS独立预测因素。
- 术前放疗与术后放疗组CSS相当。
核心结论
- 术前放疗显著改善III期直肠印戒细胞癌患者的生存结局。
研究设计与样本
- 回顾性纳入SEER项目1988至2012年II-III期直肠SRCC患者292例,行单因素和多因素Cox回归分析。
主要发现
- 292例中138例接受术前放疗,101例接受术后放疗,53例仅手术。
- 总体5年和10年CSS分别为43.8%和37.6%。
- 初步生存分析显示术前放疗较单纯手术改善CSS,尤其在III期患者中。
- 多因素分析显示术前放疗是III期直肠SRCC的CSS独立预测因素。
- 术前放疗与术后放疗组CSS相当。
临床怎么用
- 对III期直肠印戒细胞癌可考虑术前放疗以改善CSS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To investigate the clinical value of preoperative and postoperative radiotherapy (RT) in patients with rectal signet-ring cell carcinoma (SRCC). METHODS: Using the Surveillance, Epidemiology, and End Results program patients with stage II-III rectal SRCC were retrospectively included between 1988 and 2012. Univariate and multivariate Cox regression analyses were performed to analyze the effect of preoperative and postoperative RT on cause-specific survival (CSS). RESULTS: A total of 292 patients were included: 138 patients received preoperative RT, 101 patients received postoperative RT, and 53 patients underwent surgery alone. Overall, 5- and 10-year CSS was 43.8 and 37.6%, respectively. Preliminary survival analysis demonstrated that preoperative RT improved CSS versus surgery alone, especially in patients with stage III disease. Multivariate analysis demonstrated that preoperative RT was independent predictors for CSS in stage III rectal SRCC. CSS in preoperative and postoperative RT groups was comparable. CONCLUSIONS: Preoperative RT significantly improved survival outcomes in patients with stage III rectal SRCC.
引用
- Wu SG, Zhang WW, Sun JY, et al. Preoperative radiotherapy improves survival in rectal signet-ring cell carcinoma-a population-based study. Radiat Oncol. 2017. PMID: 28835256. doi:10.1186/s13014-017-0874-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。